Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Clinical and immunological profiles of anaemia in children and adolescents with Plasmodium vivax malaria in the Pará state, Brazilian Amazon.

Ventura AMRDS, Fernandes AAM, Zanini GM, Pratt-Riccio LR, Sequeira CG, do Monte CRS, Martins-Filho AJ, Machado RLD, Libonati RMF, de Souza JM, Daniel-Ribeiro CT.

Acta Trop. 2018 May;181:122-131. doi: 10.1016/j.actatropica.2018.01.022. Epub 2018 Feb 2.

PMID:
29408596
2.

Outbreak of human malaria caused by Plasmodium simium in the Atlantic Forest in Rio de Janeiro: a molecular epidemiological investigation.

Brasil P, Zalis MG, de Pina-Costa A, Siqueira AM, Júnior CB, Silva S, Areas ALL, Pelajo-Machado M, de Alvarenga DAM, da Silva Santelli ACF, Albuquerque HG, Cravo P, Santos de Abreu FV, Peterka CL, Zanini GM, Suárez Mutis MC, Pissinatti A, Lourenço-de-Oliveira R, de Brito CFA, de Fátima Ferreira-da-Cruz M, Culleton R, Daniel-Ribeiro CT.

Lancet Glob Health. 2017 Oct;5(10):e1038-e1046. doi: 10.1016/S2214-109X(17)30333-9. Epub 2017 Aug 31.

3.

New multilocus genotypes of Giardia lamblia human isolates.

Faria CP, Zanini GM, Dias GS, da Silva S, Sousa MDC.

Infect Genet Evol. 2017 Oct;54:128-137. doi: 10.1016/j.meegid.2017.06.028. Epub 2017 Jun 29.

PMID:
28669825
4.

Associations of Giardia lamblia assemblages with HIV infections and symptomatology: HIV virus and assemblage B were they born to each other?

Faria CP, Zanini GM, Dias GS, Sousa MDC.

Acta Trop. 2017 Aug;172:80-85. doi: 10.1016/j.actatropica.2017.04.026. Epub 2017 Apr 27.

PMID:
28456597
5.

Geospatial distribution of intestinal parasitic infections in Rio de Janeiro (Brazil) and its association with social determinants.

Faria CP, Zanini GM, Dias GS, da Silva S, de Freitas MB, Almendra R, Santana P, Sousa MD.

PLoS Negl Trop Dis. 2017 Mar 8;11(3):e0005445. doi: 10.1371/journal.pntd.0005445. eCollection 2017 Mar.

6.

On the cytokine/chemokine network during Plasmodium vivax malaria: new insights to understand the disease.

Hojo-Souza NS, Pereira DB, de Souza FS, de Oliveira Mendes TA, Cardoso MS, Tada MS, Zanini GM, Bartholomeu DC, Fujiwara RT, Bueno LL.

Malar J. 2017 Jan 24;16(1):42. doi: 10.1186/s12936-017-1683-5.

7.

Molecular Characterization of Giardia lamblia: First Report of Assemblage B in Human Isolates from Rio de Janeiro (Brazil).

Faria CP, Zanini GM, Dias GS, da Silva S, Sousa Mdo C.

PLoS One. 2016 Aug 12;11(8):e0160762. doi: 10.1371/journal.pone.0160762. eCollection 2016.

8.

Dengue infection as a potential trigger of an imported Plasmodium ovale malaria relapse or a long incubation period in a non-endemic malaria region.

Lupi O, Ridolfi F, da Silva S, Zanini GM, Lavigne A, Nogueira RM, da Cruz Mde F, Daniel-Ribeiro CT, Brasil P.

Int J Infect Dis. 2016 Mar;44:20-4. doi: 10.1016/j.ijid.2016.01.008. Epub 2016 Jan 22.

9.

Intestinal helminth coinfection is associated with mucosal lesions and poor response to therapy in American tegumentary leishmaniasis.

Azeredo-Coutinho RB, Pimentel MI, Zanini GM, Madeira MF, Cataldo JI, Schubach AO, Quintella LP, de Mello CX, Mendonça SC.

Acta Trop. 2016 Feb;154:42-9. doi: 10.1016/j.actatropica.2015.10.015. Epub 2015 Oct 27.

PMID:
26519200
10.

Effect of Nonspecific Chronic Low Back Pain on Walking Economy: An Observational Study.

Carvalho AR, Ribeiro Bertor WR, Briani RV, Zanini GM, Silva LI, Andrade A, Peyré-Tartaruga LA.

J Mot Behav. 2016 May-Jun;48(3):218-26. doi: 10.1080/00222895.2015.1079162. Epub 2015 Sep 24.

PMID:
26403060
11.

NO-Donor Dihydroartemisinin Derivatives as Multitarget Agents for the Treatment of Cerebral Malaria.

Bertinaria M, Orjuela-Sanchez P, Marini E, Guglielmo S, Hofer A, Martins YC, Zanini GM, Frangos JA, Gasco A, Fruttero R, Carvalho LJ.

J Med Chem. 2015 Oct 8;58(19):7895-9. doi: 10.1021/acs.jmedchem.5b01036. Epub 2015 Sep 24.

12.

Phenotypic profiling of CD8(+) T cells during Plasmodium vivax blood-stage infection.

Hojo-Souza NS, Pereira DB, Passos LS, Gazzinelli-Guimarães PH, Cardoso MS, Tada MS, Zanini GM, Bartholomeu DC, Fujiwara RT, Bueno LL.

BMC Infect Dis. 2015 Jan 31;15:35. doi: 10.1186/s12879-015-0762-x.

13.

CD4+ T cells apoptosis in Plasmodium vivax infection is mediated by activation of both intrinsic and extrinsic pathways.

Hojo-Souza NS, Pereira DB, Mendes TA, Passos LS, Gazzinelli-Guimarães AC, Gazzinelli-Guimarães PH, Tada MS, Zanini GM, Bartholomeu DC, Fujiwara RT, Bueno LL.

Malar J. 2015 Jan 5;14:5. doi: 10.1186/1475-2875-14-5.

14.

Cerebral tissue oxygenation impairment during experimental cerebral malaria.

Cabrales P, Martins YC, Ong PK, Zanini GM, Frangos JA, Carvalho LJ.

Virulence. 2013 Nov 15;4(8):686-97. doi: 10.4161/viru.26348. Epub 2013 Sep 11.

15.

Transdermal glyceryl trinitrate as an effective adjunctive treatment with artemether for late-stage experimental cerebral malaria.

Orjuela-Sánchez P, Ong PK, Zanini GM, Melchior B, Martins YC, Meays D, Frangos JA, Carvalho LJ.

Antimicrob Agents Chemother. 2013 Nov;57(11):5462-71. doi: 10.1128/AAC.00488-13. Epub 2013 Aug 26.

16.

Nitric oxide synthase dysfunction contributes to impaired cerebroarteriolar reactivity in experimental cerebral malaria.

Ong PK, Melchior B, Martins YC, Hofer A, Orjuela-Sánchez P, Cabrales P, Zanini GM, Frangos JA, Carvalho LJ.

PLoS Pathog. 2013;9(6):e1003444. doi: 10.1371/journal.ppat.1003444. Epub 2013 Jun 20.

17.

Slow and continuous delivery of a low dose of nimodipine improves survival and electrocardiogram parameters in rescue therapy of mice with experimental cerebral malaria.

Martins YC, Clemmer L, Orjuela-Sánchez P, Zanini GM, Ong PK, Frangos JA, Carvalho LJ.

Malar J. 2013 Apr 24;12:138. doi: 10.1186/1475-2875-12-138.

18.

S-nitrosoglutathione prevents experimental cerebral malaria.

Zanini GM, Martins YC, Cabrales P, Frangos JA, Carvalho LJ.

J Neuroimmune Pharmacol. 2012 Jun;7(2):477-87. doi: 10.1007/s11481-012-9343-6. Epub 2012 Mar 6.

19.

Efficacy of different nitric oxide-based strategies in preventing experimental cerebral malaria by Plasmodium berghei ANKA.

Martins YC, Zanini GM, Frangos JA, Carvalho LJ.

PLoS One. 2012;7(2):e32048. doi: 10.1371/journal.pone.0032048. Epub 2012 Feb 13.

20.

Monoclonal auto-antibodies and sera of autoimmune patients react with Plasmodium falciparum and inhibit its in vitro growth.

Brahimi K, Martins YC, Zanini GM, Ferreira-da-Cruz Mde F, Daniel-Ribeiro CT.

Mem Inst Oswaldo Cruz. 2011 Aug;106 Suppl 1:44-51.

21.

Exogenous nitric oxide decreases brain vascular inflammation, leakage and venular resistance during Plasmodium berghei ANKA infection in mice.

Zanini GM, Cabrales P, Barkho W, Frangos JA, Carvalho LJ.

J Neuroinflammation. 2011 Jun 7;8:66. doi: 10.1186/1742-2094-8-66.

22.

Nitric oxide protection against murine cerebral malaria is associated with improved cerebral microcirculatory physiology.

Cabrales P, Zanini GM, Meays D, Frangos JA, Carvalho LJ.

J Infect Dis. 2011 May 15;203(10):1454-63. doi: 10.1093/infdis/jir058. Epub 2011 Mar 16.

23.

Artemether and artesunate show the highest efficacies in rescuing mice with late-stage cerebral malaria and rapidly decrease leukocyte accumulation in the brain.

Clemmer L, Martins YC, Zanini GM, Frangos JA, Carvalho LJ.

Antimicrob Agents Chemother. 2011 Apr;55(4):1383-90. doi: 10.1128/AAC.01277-10. Epub 2011 Jan 10.

24.
25.

Murine cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction, and survival upon rescue treatment is markedly increased by nimodipine.

Cabrales P, Zanini GM, Meays D, Frangos JA, Carvalho LJ.

Am J Pathol. 2010 Mar;176(3):1306-15. doi: 10.2353/ajpath.2010.090691. Epub 2010 Jan 28.

26.

Sera of patients with systemic lupus erythematosus react with plasmodial antigens and can inhibit the in vitro growth of Plasmodium falciparum.

Zanini GM, De Moura Carvalho LJ, Brahimi K, De Souza-Passos LF, Guimarães SJ, Da Silva Machado E, Bianco-Junior C, Riccio EK, De Sousa MA, Alecrim MD, Leite N, Druilhe P, Daniel-Ribeiro CT.

Autoimmunity. 2009 Sep;42(6):545-52. doi: 10.1080/08916930903039810.

PMID:
19657771
27.

Similar cytokine responses and degrees of anemia in patients with Plasmodium falciparum and Plasmodium vivax infections in the Brazilian Amazon region.

Fernandes AA, Carvalho LJ, Zanini GM, Ventura AM, Souza JM, Cotias PM, Silva-Filho IL, Daniel-Ribeiro CT.

Clin Vaccine Immunol. 2008 Apr;15(4):650-8. doi: 10.1128/CVI.00475-07. Epub 2008 Feb 6.

28.

Longitudinal clinical and serological survey of abdominal angiostrongyliasis in Guaporé, southern Brazil, from 1995 to 1999.

Graeff-Teixeira C, Goulart AH, Brum Cde O, Laitano AC, Sievers-Tostes C, Zanini GM, Bered PL, Morassutti A, Geiger S, Abrahms-Sandi E, Oliveira FT, Maurer RL, Aguiar LF, Garrido CT, da Silva AC, Rodriguez R, Schulz-Key H, Agostini AA.

Rev Soc Bras Med Trop. 2005 Jul-Aug;38(4):310-5. Epub 2005 Aug 3.

29.

A new job: research volunteer?

Zanini GM, Marone C.

Swiss Med Wkly. 2005 May 28;135(21-22):315-7.

PMID:
16034685
30.
31.

Immunization of Saimiri sciureus monkeys with Plasmodium falciparum merozoite surface protein-3 and glutamate-rich protein suggests that protection is related to antibody levels.

Carvalho LJ, Oliveira SG, Theisen M, Alves FA, Andrade MC, Zanini GM, Brígido MC, Oeuvray C, Póvoa MM, Muniz JA, Druilhe P, Daniel-Ribeiro CT.

Scand J Immunol. 2004 Apr;59(4):363-72.

33.

Swiss regulations for controlling clinical trials.

Zanini GM.

Pharmacol Res. 1998 Apr;37(4):321-32.

PMID:
9634649
34.

Inexpensive alternative material for the isolation of larvae with the Baermann method.

Graeff-Teixeira C, Medeiros E, Zanini GM, Brasil CA, Cardozo BL, Dalpiaz MG, Bisol LW.

Mem Inst Oswaldo Cruz. 1997 May-Jun;92(3):399-400. No abstract available.

35.

Supplemental Content

Loading ...
Support Center